{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-000027","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2026-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.922166+00:00","generated_at":"2026-05-16T11:47:24.099900+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Sonoma Pharmaceuticals grants annual equity to executives and directors","bullets":["Non-employee directors each received 10,000 options at $3.68, vesting in 3 equal annual tranches.","CEO Amy Trombly received 10,000 RSUs vesting on the third anniversary or upon change of control.","CFO Jerry Dvonch received 5,000 RSUs vesting on the third anniversary or upon change of control."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-000027","json":"https://secwatch.observer/filing/0001683168-26-000027.json","markdown":"https://secwatch.observer/filing/0001683168-26-000027.md","text":"https://secwatch.observer/filing/0001683168-26-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826000027/0001683168-26-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826000027/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:47:24.099900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}